MediPharm Labs (OTC: MEDIF) has nabbed a customer Down Under. The company announced Wednesday that its Australian subsidiary signed an agreement with privately held Compass Clinics for the supply of cannabis oil products. This is a white label arrangement, in which Compass Clinics will use MediPharm's supplies to create its own branded line of products.
MediPharm didn't reveal the terms or the price of the deal.
The news comes less than two months after MediPharm announced it secured a license from the Australian government to import cannabis and related substances from its native Canada.